Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-26-005024
Filing Date
2026-05-18
Accepted
2026-05-18 06:29:35
Documents
1
Period of Report
2026-05-18

Document Format Files

Seq Description Document Type Size
1 JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR a5853e.htm 6-K 67177
  Complete submission text file 0001654954-26-005024.txt   68432
Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG
Business Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG 44 20 8047 5000
GSK plc (Filer) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 26990728
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)